Chief Technology Officer
Mission Bio, Inc
Adam Sciambi, PhD is a co-founder and CTO of Mission Bio, Inc. As a postdoc in the Abate Lab at the University of California, San Francisco, he developed Mission Bio’s core technology to simultaneously genotype and phenotype thousands of individual cells at once. Since the company’s launch in 2014, he has helped to drive the associated Tapestri platform to perform rare cell characterization for AML MRD, examine the zygosity of gene edits in CAR-T therapy, and correlate the clonal evolution of chromosomal abnormalities with druggable surface markers in multiple myeloma.